Sanergy franchises sanitation units across Nairobi’s urban slums, offering an affordable and effective alternative to places without adequate sewage infrastructure. By 2020, it plans to have an active network of 4,900 Fresh Life Toilets that will serve approximately 36 percent of the population (200,000 people) in Mukuru.
Impact Medical Strategies seeks to transform lives of patients all over the world by developing novel medical devices and diagnostics, which have the potential to impact global health.
Procare has developed a novel biomarker that may improve the detection of prostate cancer, which will better focus care for patients at the highest risk, prevent needless biopsies, and save healthcare costs. They are currently developing a lab assay and a rapid point-of-care (POC) test.
KleenGel is an automatic, infrared device designed to efficiently and hygienically dispense lubricating gel for use by healthcare providers. It eliminates the need to touch a tube or packet of lubricating gel and prevents cross-contamination during pelvic and rectal exams.
Ovation Diagnostics is a cancer diagnostics company committed to improving the detection of ovarian cancer. Using a novel biomarker present in urine samples of ovarian cancer patients, they are developing a rapid laboratory test that will offer women an efficient, noninvasive, and affordable method of detecting ovarian cancer.
NanoSmart has developed several patented drug-delivery systems that can reformulate already approved cancer drugs to make them safer and more effective.
LegWorks believes mobility is empowerment and walking to be an essential part of interacting in life, being able to work, and taking care of oneself and one's family. It builds partnerships to supply prosthetic knees to people in developing countries who would typically not have the access or funds to buy their own.
ClearSpec is a manufacturer and supplier of advanced disposable speculums designed to save physicians time while increasing the quality of care. The speculums allow for more visibility than others on the market as their design creates less viewing obstruction. They also feature a high powered LED illuminator, while also minimizing patient discomfort.
APT's mission is to develop an effective treatment that will safely prolong pregnancy, allowing babies more time to develop in the womb. It has several patents either granted or pending that cover a broad range of medical technology for the treatment of preeclampsia.